Abstract
Sex is shown to affect various aspects of the clinical spectrum of ischaemic stroke, from how an individual patient may present with ischaemic stroke through to how they respond to treatment strategies. In this chapter, we review the evidence for the effect of sex on ischaemic stroke and focus on how the pathological mechanisms of ischaemic stroke, in particular apoptosis, may differ between the sexes. Understanding sex-specific consequences of ischaemic stroke may enable the development of relevant and effective treatment strategies for an individual suffering an ischaemic stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIF:
-
Apoptosis-inducing factor
- ENOS:
-
Efficacy of Nitric Oxide in Stroke
- NIH:
-
National Institutes of Health
- NOS:
-
Nitric oxide synthase
- PARP:
-
Poly-ADP ribose polymerase
- SITS-ISTR:
-
Stroke-International Stroke Thrombolysis Register
- STAIR:
-
Stroke Treatment Academic Industry Roundtable
- tPA:
-
Tissue plasminogen activation
References
Gibson CL (2013) Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab 33:1355–1361
Rojas JI, Zurru MC, Romano M, Patrucco L, Cristiano E (2007) Acute ischemic stroke and transient ischemic attack in the very old—risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 14:895–899
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB et al (2006) The lifetime risk of stroke: estimates from the Framingham study. Stroke 37:345–350
Gargano JW, Wehner S, Reeves MJ (2009) Delays among patients with acute stroke. Do presenting symptoms explain sex differences in emergency department? Stroke 40:1114–1120
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al (2008) Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146
Thorvaldsen P, Asplund KM, Kuulasmaa K, Rajakangas AM, Scholl M (1995) Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health organization monitoring trends and determinants in cardiovascular disease. Stroke 26:361–367
Towfighi A, Saver JL, Engelhardt R, Ovbiagele B (2007) A midlife stroke surge among women in the United States. Neurology 69:1898–1904
Lofmark U, Hammartstrom A (2007) Evidence for age-dependent education-related differences in men and women with first-ever stroke. Neuroepidemiology 28:135–141
Rothwell PM, Coull AJ, Silver LE et al (2005) Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366:1970–1975
Jerath NU, Reddy C, Freeman D, Jerath AU, Brown RD (2011) Gender differences in presenting signs and symptoms of acute ischemic stroke: a population-based study. Gend Med 8:312–319
Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735–2740
Mandelzweig L, Goldbourt U, Bokyo V, Tanne D (2006) Perceptual, social, and behavioural factors associated with delays in seeking medical care in patient with symptoms of acute stroke. Stroke 37:1248–1253
Di Carlo A, Lamassa M, Baldereschi M et al (2003) Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 34:1114–1119
Benatru I, Rouaud O, Durier J et al (2006) Stable stroke incidence rates but improved case-fatality 06 in Dijon, France, from 1985 to 2004. Stroke 37:1674–1679
Olsen TS, Dehlendorff C, Andersen KK (2007) Sex-related time-dependent variations in post-stroke survival: evidence of a female stroke survival advantage. Neuroepidemiology 29:218–225
Fukuda M, Kanda T, Kamide N, Akutsu T, Sakai F (2009) Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern Med 48:967–973
Gray LJ, Sprigg N, Bath PMW, Boysen G, De Deyn PP, Leys D et al (2007) Sex differences in quality of life in stroke survivors. Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 8(11):2960–2964
Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD (1998) Gender-linked brain injury in experimental stroke. Stroke 29:159–166
Toung TJ, Hurn PD, Traystman RJ, Sieber FE (2000) Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type I diabetes mellitus. Stroke 31:2701–2706
Gibson CL, Gray LJ, Murphy SP, Bath PMW (2006) Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 26:1103–1113
Gibson CL, Bath PM (2015) Feasibility of progesterone treatment for ischemic stroke. J Cereb Blood Flow Metab 25:431–439
Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Makuch R, Horwitz RJ (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345:1243–1249
Heyer A, Hasselblatt M, von Ahsen N, Hafner H, Siren AL, Ehrenreich H (2005) In vitro gender differences in neuronal survival on hypoxia in 17B-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab 25:317–321
Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD (2005) Sex differences in cell death. Ann Neurol 58:317–321
Carruth LL, Reisert I, Arnold AP (2002) Sex chromosome genes directly affect brain sexual differentiation. Nat Neurosci 5:933–934
Renolleau S, Fau S, Charriau-Marlangue C (2008) Gender-related differences in apoptotic pathways after neonatal cerebral ischemia. Neuroscientist 14:46–52
Park EM, Cho S, Frys KA, Glickstein SB, Zhou P, Anrather J et al (2006) Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J Cereb Blood Flow Metab 26:392–401
Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K et al (2006) Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischemia. J Neurochem 96:1016–1027
Cordeau P Jr, Lalancette-Herbert M, Weng YC, Krizz J (2008) Live imaging of neuroinflammation reveals sex and estrogen effects on astrocytic response to ischemic injury. Stroke 39:935–942
Sakata A, Mogi M, Iwanami J, Tsukuda K, Min L-J, Fujita T et al (2009) Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res 1300:14–23
Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306:990–995
Puyal J, Vaslin A, Mottier V, Clarke PG (2009) Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol 66:378–389
Towfighi A, Markovic D, Ovbiagele B (2013) Sex differences in revascularization interventions after acute ischemic stroke. J Stroke Cerebrovasc Dis 22:e347–e353
Boehme AK, Siegler JE, Mullen MT, Albright KC, Lyerly MJ (2014) Monlezun D, J et al. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 23:e255–e261
Kent DM, Price LL, Ringleb P, Hill MD, Selker HP (2005) Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke a pooled analysis of randomized clinical trials. Stroke 36:62–65
Kent DM, Buchan AM, Hill MD (2008) The gender effect in stroke thrombolysis: Of CASES, controls and treatment-effect modification. Neurology 71:1080–1083
Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C et al (2013) Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answers from safe implementation of treatments in stroke-international stroke thrombolysis stroke register. Stroke 44:3401–3406
Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947
Group SCotPHSR (1989) Final report on the aspirin component of the ongoing physicians’ health study. Steering committee of the Physicians’ Health Study Research Group. N Engl J Med 321:129–135
Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D (2009) Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemostat 101:938–942
Bath PMW, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, Bereczki D et al (2015) Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 385(9968):617–628
Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G et al (2015) Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial. Stroke 46(11):3194–3201
Bath PMW, Blecic S, Bogousslavsky J, Boysen G, Davis S, Diez-Tejedor E et al (2000) Tirilazad mesylate in acute ischemic stroke - a systematic review. Stroke 31(9):2257–2265
Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SA et al (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40:2244–2250
Li J, McCullough LD (2009) Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab 29:670–674
Amiri-Nikpour MR, Nazarbaghi S, Hamdi-Holasou M, Rezaei Y (2015) An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect. Acta Neurol Scand 131:45–50
McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD (2005) Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 25:502–512
Couturier JY, Ding-Zhou L, Croci N, Plotkine M, Margaill I (2003) 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. Exp Neurol 184:973–980
Hamby AM, Suh SW, Kauppinen TM, Swanson RA (2007) Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38:632–636
Matsuura S, Egi Y, Yuki S, Horikawa T, Satoh H, Akira T (2011) MP-124, a novel poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model. Brain Res 1410:122–131
Gibson CL, Gray LJ, Bath PMW, Murphy SM (2008) Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131:318–328
Wagner AK, Bayir H, Ren D, Puccio A, Zafonte RD, Kochanek PM (2004) Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age and hypothermia. J Neurotrauma 21:125–136
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gibson, C.L., Bath, P.M.W., Altaee, R. (2017). Stroke Sex Differences: From Basic Research to Clinical Trials. In: Lapchak, P., Zhang, J. (eds) Neuroprotective Therapy for Stroke and Ischemic Disease. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-45345-3_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-45345-3_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45344-6
Online ISBN: 978-3-319-45345-3
eBook Packages: MedicineMedicine (R0)